Kay Olmstead
Director/Board Member at BENO TNR, INC.
Profile
Kay Olmstead is the founder and current CEO & Director of Nano PharmaSolutions, Inc., a company founded in 2019.
She is also currently a Director at BENO TNR, Inc.
Kay Olmstead active positions
| Companies | Position | Start |
|---|---|---|
| BENO TNR, INC. | Director/Board Member | - |
Nano Pharmasolutions, Inc.
 Nano Pharmasolutions, Inc. Pharmaceuticals: MajorHealth Technology Nano Pharmasolutions, Inc. is a pharmaceutical company based in an undisclosed location. Nano Pharmasolutions is developing a dry powder for inhalation (DPI) formulation of remedesivir to fight COVID-19. The American company's platform is based on physical vapor deposition (PVD) technology, which allows them to make drug nanoparticles with no excipients or solvents. These nanodrug particles can be used in various forms such as pills, nasal sprays, creams/salves, inhalers, and eye drops. The private company's nanotransformer™ technology can create an e-8 torr vacuum, and it uses carrier solids selected from hydrophilic pharmaceutical excipients to deposit vapor phase drugs as nanoparticles on fast-moving carriers. The company was founded by Kay Olmstead, Saeyeon Lee, Seok-Keun Koh, and Kay Olmstead has been the CEO since incorporation. | Founder | 2019-05-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BENO TNR, INC. | Technology Services |
| Private companies | 1 |
|---|---|
Nano Pharmasolutions, Inc.
Nano Pharmasolutions, Inc. Pharmaceuticals: MajorHealth Technology Nano Pharmasolutions, Inc. is a pharmaceutical company based in an undisclosed location. Nano Pharmasolutions is developing a dry powder for inhalation (DPI) formulation of remedesivir to fight COVID-19. The American company's platform is based on physical vapor deposition (PVD) technology, which allows them to make drug nanoparticles with no excipients or solvents. These nanodrug particles can be used in various forms such as pills, nasal sprays, creams/salves, inhalers, and eye drops. The private company's nanotransformer™ technology can create an e-8 torr vacuum, and it uses carrier solids selected from hydrophilic pharmaceutical excipients to deposit vapor phase drugs as nanoparticles on fast-moving carriers. The company was founded by Kay Olmstead, Saeyeon Lee, Seok-Keun Koh, and Kay Olmstead has been the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Kay Olmstead
